Tag: Senak


FDA Social Media Draft Guidances Answer Some Questions, Raise Others

July 21, 2014 – Although the FDA has attempted to provide some clarity on its position regarding certain social media issues and practices, the agency’s recent draft guidance documents do not leave industry communicators with a crystal clear path and, indeed, “raise some important questions that communicators may have for their counsel,” according to Mark […]

Read more

Eye on FDA Data Analysis Shows Videos Are Cited Most for Risk Minimization, Overstatement of Efficacy

Nov. 7, 2012 – Analysis of the FDA’s Office of Prescription Drug Promotion’s regulatory action letters since 2005 shows that although risk minimization and overstatement of efficacy are the most frequently cited alleged violations across the full array of media (64 percent combined), that number goes up considerably – to 80 percent combined – when […]

Read more